European science is in a strong position, Stefan Oelrich, President of Bayer’s Pharmaceuticals ... Bill Anderson, CEO, at Roche Pharmaceuticals, agreed that Europe had a promising scientific ...

Eli Lilly’s big-selling insulin, Humalog, faces cut-price competition after the US regulator approved a biosimilar from Sanofi. Sanofi’s Admelog (insulin lispro) is approved in type 1 and type ...

The website you are visiting is protected and accelerated by Imperva. Your computer may have been infected by malware and ...

Bayer was ordered to pay more than $2 billion by a jury in a Georgia state court in the latest legal case surrounding alleged ...

FRANKFURT, March 26 (Reuters) - Bayer (BAYGn.DE), opens new tab said ... in the first phase of clinical trials. Sign up here. Healthcare & Pharmaceuticalscategory US to end funding for childhood ...

Conducted by B.E. Smith, a leading provider of healthcare executive search services and a company of AMN Healthcare, the 2025 Healthcare Leadership Trends survey reflects the overall state of ...

Elliott Management held talks with private equity groups in recent months to gauge interest in buying Bayer’s (BAYRY) consumer health business, ...

Bayer ( OTCPK:BAYZF) ( OTCPK:BAYRY) dropped significantly after a Georgia state jury ordered the company to pay $2.1 billion in a case involving its Roundup weedkiller. The decision, delivered in Cobb ...

The move comes less than a month after Amazon One Medical CEO Trent Green said he would be departing the company. Dr. Gupta joined professional services firm Manatt, Phelps & Phillips, while Mr ...

ALSO SEE: New Jersey home of a prominent Bayer executive targeted in alleged arson, sources say Friday's decision marks the fourth Roundup-related verdict that Findley's team has won to date - the ...

On Thursday, February 20th, Saurabh Saha sold 55,000 shares of Centessa Pharmaceuticals stock. The shares were sold at an average price of $15.93, for a total transaction of $876,150.00.